| 10730951 |
Anti-OX40 antibodies and methods of use |
Changchun DU, Jeong Ho Kim, Jing Zhu, Jack BEVERS, III, Kevin Walsh +2 more |
2020-08-04 |
| 9975957 |
Anti-OX40 antibodies and methods of use |
Changchun DU, Jeong Ho Kim, Jing Zhu, Jack BEVERS, III, Kevin Walsh +2 more |
2018-05-22 |
| 9283273 |
Protein formulation |
Jeffrey L. Cleland, Chung-Chiang Hsu, Xanthe M. Lam, David E. Overcashier, Steven J. Shire +2 more |
2016-03-15 |
| 9180189 |
Treating a mammal with a formulation comprising an antibody which binds IgE |
Chung-Chiang Hsu, Steven J. Shire, Sylvia Sau-Yan Wu |
2015-11-10 |
| 9017671 |
Method of treating cancer with a pharmaceutical formulation comprising a HER2 antibody |
SHIANG C. GWEE, Jun Liu, Ye Shen |
2015-04-28 |
| 8372396 |
Antibody formulations |
SHIANG C. GWEE, Jun Liu, Ye Shen |
2013-02-12 |
| 7682609 |
Protein formulation |
Jeffrey L. Cleland, Chung-Chiang Hsu, Xanthe M. Lam, David E. Overcashier, Steven J. Shire +2 more |
2010-03-23 |
| 7060268 |
Protein formulation |
Jeffrey L. Cleland, Chung-Chiang Hsu, Xanthe M. Lam, David E. Overcashier, Steven J. Shire +2 more |
2006-06-13 |
| 6685940 |
Protein formulation |
Jeffrey L. Cleland, Chung-Chiang Hsu, Xanthe M. Lam, David E. Overcashier, Steven J. Shire +2 more |
2004-02-03 |
| 6267958 |
Protein formulation |
Jeffrey L. Cleland, Chung-Chiang Hsu, Xanthe M. Lam, David E. Overcashier, Steven J. Shire +2 more |
2001-07-31 |
